Live Quote · NASDAQALLOHealthcare· Biotechnology

Allogene Therapeutics, Inc.

$0.63▼ 5.88%($-0.04)
MKT CAP $217.48MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
47
Valuation
40
Profitability
55
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ALLO research report →

Analyst Price Target
$6.43+924.4% vs. today

Range $3.85 – $9

Analyst RatingBuy
19 Buy10 Hold1 Sell

Price Chart

-47.07% · this period
$3.06$1.86$0.67Nov 19May 22Nov 19
52-Week Range0% of range
Low
$0.62
Current
$0.63
High
$4.46